How do you approach a CR in stage II nonbulky and unfavorable Hodgkin lymphoma after 2 cycles of ABVD?

Do you continue using a RATHL-style appraoch? Do you incorporate radiotherapy? When do you utilize brentuximab-nivolumab or other novel approaches currently utilized in trial-based settings?